Renasant Bio
Home | RenasantBio
United States · $54.5M raised
- Employees
- 11–50
- Business Model
- B2B
- Website
- renasantbio.com
- Total Funding
- $54.5M
- Last Round
- $54.5M SeedJul 2025
- Rounds
- 1
About
Biotech company pioneering small molecule therapies for autosomal dominant polycystic kidney disease (ADPKD).
Summary
Renasant Bio is a Biotech company based in United States. It has raised $54.5M in total across 1 round, most recently a $54.5M Seed round in Jul 2025. Investors include 5AM Ventures, Atlas Venture and OrbiMed.
Tech & App Stack
1 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jul 2025
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Specialty pharmaceutical company
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...